Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Haircuts and medical growth factors do not cause cancer.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

A group has developed therapies that show promise for treating cancer and various other conditions.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Docetaxel treatment for breast cancer can cause permanent hair loss.

High dose rate electronic brachytherapy is an effective and safe non-surgical treatment for nonmelanoma skin cancer with good cosmetic results after three years.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Finasteride's effects on prostate cancer are not clear from this text.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Male pattern baldness may be linked to prostate cancer risk.

Men and women may have different risks of getting skin cancer.